Insulet | Los Gastos De Explotación



Operating Expenses Cambio Fecha
Abbott USD 9.06B 298M 2024-12
Align Technology USD 851.07M 35.5M 2024-12
AtriCure USD 138.8M 15.48M 2024-12
Avanos Medical USD 598.1M 439.7M 2024-12
Baxter International USD 3.19B 644M 2024-12
Becton, Dickinson and Co. USD 4.72B 74M 2024-12
Boston Scientific USD 3.89B 410M 2024-12
Cardinal Health USD 54.72B 3.01B 2024-12
Cooper Companies USD 782.7M 37.3M 2025-01
Dexcom USD 924.6M 82.4M 2024-12
Edwards Lifesciences USD 1.07B 69.4M 2024-12
Eli Lilly USD 8.38B 1.53B 2024-12
Globus Medical USD 597.02M 19.41M 2024-12
ICU Medical USD 592.11M 11.22M 2024-12
Insulet USD 488.2M 32.4M 2024-12
Integra LifeSciences USD 407.42M 18.45M 2024-12
J&J USD 18.63B 500M 2024-12
Masimo USD 959.8M 485.3M 2024-12
Medtronic USD 6.65B 162M 2025-01
Merit Medical Systems USD 318.59M 16.01M 2024-12
Roche Holding CHF 11.43B 1.48B 2024-12
Solventum Corp 1.94B 131M 2024-12
Stryker USD 5.86B 1.45B 2024-12
Tandem Diabetes Care USD 283.23M 13.17M 2024-12
Teleflex USD 905.79M 290.73M 2024-12
West Pharmaceutical Services USD 589.2M 3.6M 2024-12
Zimmer Biomet Holdings USD 1.63B 89.5M 2024-12



Insulet Los Gastos De Explotación - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.